We discuss two studies on colorectal cancer that were presented at the ESMO World Congress on Gastrointestinal Cancer. We also talk about a recently published study on the prevalence of pain among cancer survivors in the U.S.

Coverage of stories discussed this week on ascopost.com:

BEACON CRC: Encorafenib/Binimetinib/Cetuximab Improves Survival in BRAFV600E–Mutated Metastatic Colorectal Cancer

REARRANGE Trial Examines Flexible Regorafenib Dosing in Refractory Metastatic Colorectal Cancer

Chronic Pain in U.S. Cancer Survivors